Pharmaceutical
Technology
Health
Cleveland BioLabs
$1.459876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$1.45
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.00 (-0.28%) Today
-$0.03 (-1.75%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell CBLI and other stocks, options, ETFs, and crypto commission-free!
About CBLI
Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. Read More It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY.
CEO
Employees
16
Headquarters
Buffalo, New York
Founded
2003
Market Cap
16.50M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
2.68K
High Today
$1.45
Low Today
$1.45
Open Price
$1.45
Volume
2.54K
52 Week High
$3.16
52 Week Low
$1.00
Collections
Pharmaceutical
Technology
Health
Biotechnology
Biopharmaceutical
Research And Development
US
North America
Price Paid on Robinhood
33% Lower
Right Now
52 Week Low
$1.00
Average Price Paid
$2.18
52 Week High
$3.16
CBLI Earnings
-$0.11
-$0.09
-$0.06
-$0.04
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 13, Pre-Market